English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The role of perioperative chemotherapy (POC) and targeted therapies in lung metastasectomy for colorectal cancer (CRC) is still subject to debate. We aimed to evaluate whether POC and targeted therapies were associated with different outcomes according to the mutational status.

european journal of cardio-thoracic surgery

Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouring<i>v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue</i>exon 2 codon 12 mutations†

Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouringv-Ki-ras2 Kirsten rat sarcoma viral oncogene homologueexon 2 codon 12 mutations†